Company Filing History:
1 out of 1,289 
1 out of 13 Years Active: 2019
Title: The Innovative Contributions of Marcus Krüger
Introduction
Marcus Krüger is a notable inventor based in Bad Nauheim, Germany. He has made significant contributions to the field of cancer research, particularly through his innovative patent related to cancer diagnosis and therapy. His work focuses on the identification of specific isoforms that can serve as markers for lung cancer.
Latest Patents
Marcus Krüger holds a patent titled "Isoforms of GATA6 and NKX2-1 as markers for diagnosis and therapy of cancer and as targets for anti-cancer therapy." This invention outlines a method for assessing whether a subject suffers from cancer or is predisposed to it, specifically lung cancer. The method involves measuring the amounts of specific isoforms of GATA6 and/or NKX2-1 in a sample from the subject. Additionally, the patent describes a composition for medical use that includes inhibitors of these isoforms, as well as a kit designed for assessing cancer susceptibility.
Career Highlights
Throughout his career, Marcus Krüger has been associated with prestigious institutions such as the Max Planck Society for the Advancement of Science and Justus Liebig University Giessen. His work in these organizations has contributed to advancements in medical research and cancer therapy.
Collaborations
Marcus has collaborated with notable colleagues, including Guillermo Barreto and Aditi Mehta. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation in cancer diagnostics.
Conclusion
Marcus Krüger's contributions to cancer research through his innovative patent demonstrate his commitment to improving diagnostic methods and therapeutic options. His work continues to impact the field significantly.